Clin2
NCT07535606Likely a fitActive, not recruiting

Safety Study of ALN-4915 in Healthy Adults

Healthy Volunteers

This is an early-stage study testing a new investigational medicine called ALN-4915 in healthy volunteers. Researchers want to learn if it is safe and how the body processes it.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
36 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You must be in generally good health with no serious medical conditions
  • Your liver function tests (ALT and AST) must be normal or below the upper limit of normal
  • Your total bilirubin level must be normal or below the upper limit of normal
  • You must be willing and able to complete all study visits and assessments
  • You should not have a known deficiency in your immune system or complement proteins

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07295717Recruiting· Phase 1
ALN-4285 safety study in healthy adults

This study tests a new medicine called ALN-4285 in healthy adults to see how safe it is and how the body processes it. It may help find a new treatment for certain conditions.

London
NCT07829406Not yet recruiting· Phase 1
Safety study of a new medicine in healthy adults

This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.

Salt Lake City, Utah
NCT07797855Recruiting· Phase 1
Testing a new medicine's safety in healthy people

This study tests a new medicine called NNC0705-0002 in healthy volunteers to see if it is safe and how the body handles it. It helps find the right dose for future studies.

Groningen
NCT05648214Recruiting· Phase 1/Phase 2
Testing a new liver medicine in people with fatty liver

This early-phase study tests whether ALN-PNP is safe and well tolerated, first in healthy adults and then in adults with MASLD (fatty liver disease). If you have MASLD, it may help researchers learn whether this medicine is a promising option for treating liver fat buildup.

Glendale, California
NCT07522970Recruiting· Phase 1
Safety and Tolerability Study of LG-0317 in Healthy Adults

This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.

Shanghai, Shanghai Municipality
NCT06995326Not yet recruiting· Phase 1
Study of an experimental medicine in healthy volunteers

This trial tests a new medicine in healthy people to see how safe it is and how the body handles it. It may help pave the way for future treatments.

Hear when a new Healthy Volunteers trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.